
Busan City Rolls Out Novavax XBB.1.5 COVID-19 Vaccine, Expanding Free Immunization to All Citizens Aged 12 and Above
Busan, South Korea – Marking a major step in its COVID-19 vaccination efforts, Busan City has announced the launch of the Novavax XBB.1.5 vaccine, adding to its arsenal of Pfizer and Moderna's XBB.1.5 formulations. Effective today, the city embarks on a widespread, free vaccination campaign targeting all residents aged 12 and up, slated to run until March of the following year. Employing recombinant genetic technology akin to that used in hepatitis B and influenza vaccines, the Novavax XBB.1.5










